These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32521616)

  • 61. Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
    Jao J; Yu W; Patel K; Miller TL; Karalius B; Geffner ME; DiMeglio LA; Mirza A; Chen JS; Silio M; McFarland EJ; Van Dyke RB; Jacobson D;
    HIV Med; 2018 Mar; 19(3):175-183. PubMed ID: 29159965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
    Kileel EM; Malvestutto CD; Lo J; Fitch KV; Fichtenbaum CJ; Aberg JA; Zanni MV; Martinez E; Okeke NL; Kumar P; Joao E; Bares SH; Berrner D; Smieja M; Roa JC; McCallum S; Douglas PS; Ribaudo HJ; Grinspoon SK
    Clin Infect Dis; 2023 Jun; 76(11):2010-2013. PubMed ID: 36825498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Weight Gain: A Possible Side Effect of All Antiretrovirals.
    Taramasso L; Ricci E; Menzaghi B; Orofino G; Passerini S; Madeddu G; Martinelli CV; De Socio GV; Squillace N; Rusconi S; Bonfanti P; Di Biagio A;
    Open Forum Infect Dis; 2017; 4(4):ofx239. PubMed ID: 29255735
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of Serum Creatinine Changes With Integrase Inhibitor Use in Human Immunodeficiency Virus-1 Infected Adults.
    Lindeman TA; Duggan JM; Sahloff EG
    Open Forum Infect Dis; 2016 Mar; 3(2):ofw053. PubMed ID: 27092314
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adults with Perinatally Acquired HIV; Emerging Clinical Outcomes and Data Gaps.
    Henderson M; Fidler S; Foster C
    Trop Med Infect Dis; 2024 Apr; 9(4):. PubMed ID: 38668535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir - based antiretroviral therapy start in Kampala, Uganda.
    Nakatudde I; Katana E; Agnes Odongpiny EL; Nalugga EA; Castelnuovo B; Fowler MG; Musoke P
    AIDS Res Ther; 2024 Apr; 21(1):23. PubMed ID: 38637785
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Weight Gain in Overweight and Obese People with HIV-The OBHIV Cohort.
    Taramasso L; Dettori S; Ricci E; Lerta S; Mora S; Blanchi S; Giacomini M; Vena A; Bassetti M; Di Biagio A
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592054
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
    Compagnucci A; Chan MK; Saïdi Y; Cressey TR; Bamford A; Riault Y; Coelho A; Nolan A; Chalermpantmetagul S; Morkunaite G; Amuge P; Musiime V; Violari A; Cotton M; Kekitiinwa AR; Kaudha E; Groenewald M; Liberty AA; Kanjanavanit S; Volokha A; Bologna R; Pavia Ruz N; Prieto Tato L; Paioni P; Marques L; Reliquet V; Niehues T; Welch SB; Ford D; Giaquinto C; Gibb DM; Babiker A; Ramos Amador JT;
    EClinicalMedicine; 2023 Jun; 60():102025. PubMed ID: 37304494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda.
    Guaraldi G; Bonfanti P; Di Biagio A; Gori A; Milić J; Saltini P; Segala FV; Squillace N; Taramasso L; Cingolani A
    BMC Infect Dis; 2023 Apr; 23(1):230. PubMed ID: 37060030
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy.
    Dirajlal-Fargo S; McComsey GA
    Curr HIV/AIDS Rep; 2021 Oct; 18(5):424-435. PubMed ID: 34652624
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort.
    Koay WLA; Dirajlal-Fargo S; Levy ME; Kulie P; Monroe A; Castel AD; Rakhmanina NY;
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab308. PubMed ID: 34295943
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV.
    Guaraldi G; Milic J; Bacchi E; Carli F; Menozzi M; Franconi I; Raimondi A; Ciusa G; Masi V; Belli M; Guaraldi S; Aprile E; Mancini M; Mussini C; Lake JE; Erlandson KM
    HIV Res Clin Pract; 2022 Nov; 24(1):1-6. PubMed ID: 36883678
    [No Abstract]   [Full Text] [Related]  

  • 73. Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
    Raffi F; Esser S; Nunnari G; Pérez-Valero I; Waters L
    HIV Med; 2016 Oct; 17 Suppl 5():3-16. PubMed ID: 27714978
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Switching to Integrase Inhibitors Unlinked to Weight Increase in Perinatally HIV-Infected Young Adults and Adolescents: A 10-Year Observational Study.
    Taramasso L; Di Biagio A; Bovis F; Forlanini F; Albani E; Papaioannu R; Giacomet V
    Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32521616
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of a treatment switch to integrase Strand transfer inhibitor-based regimens on weight gain and other metabolic syndrome-related conditions.
    Maman O; Ahmad WA; Perzon O; Mahlab-Guri K; Elbirt D; Elinav H
    BMC Infect Dis; 2024 Feb; 24(1):221. PubMed ID: 38373940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
    Verboeket SO; Boyd A; Wit FW; Verheij E; Schim van der Loeff MF; Kootstra N; van der Valk M; Reiss P;
    PLoS One; 2021; 16(5):e0251205. PubMed ID: 33951089
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.